Tibet AIM Pharm. Inc.

Direct answer

Tibet AIM Pharm. Inc. is publicly traded on SHZ under the ticker 002826.SZ.

Headquartered in Beijing, China, Tibet AIM Pharm. Inc. was established in 2003 to conduct research and develop medical products across China. The company's diverse pharmaceutical portfolio targets a range of health conditions. Among its offerings are Miglitol tablets for managing diabetes and Gualoupi injection, prescribed for coronary disease. It also provides Oxytocin injection for gynecological and obstetric...

Can you invest in Tibet AIM Pharm. Inc.?

Yes. Tibet AIM Pharm. Inc. is publicly traded on SHZ under the ticker 002826.SZ.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Tibet AIM Pharm. Inc.

Detailed equity research is provided by MarketSnap.